Navigation Links
NimbleGen names CFO with capital-raising past

Madison, Wis. - NimbleGen Systems, Inc., a supplier of DNA microarrays for genome research, has appointed a new chief financial officer with experience managing large entrepreneurial growth companies.

David Snyder brings more than 15 years of experience in capital raising, finance, and general management in a range of industries, including te......

Full article >>> ded on the Nasdaq.

In addition, Snyder worked for Eagle Industries, Inc., a diversified manufacturing company sponsored by Chicago entrepreneur Sam Zell. Eagle Industries grew to nearly $2 billion in revenue.

Snyder graduated from the Harvard Business School, where he was designated as a Baker Scholar.

Full article >>>
'"/>

Source:wistechnology.com By Chris Fleissner 08/07/06


Related biology technology :

1. NimbleGen researcher to lead $415K DNA project
2. NimbleGen to discontinue IPO after Roches $272.5 million acquisition
3. IPO-bound NimbleGen traveling in fast company
4. Madison biotech NimbleGen files for IPO; one of states best-funded firms
5. Genomics researcher Hood joins NimbleGen board
6. NimbleGen partners with UK biotech firm
7. NimbleGen extends research market reach
8. NimbleGen microarrays speed genetic findings
9. NimbleGen partners with leading researchers
10. NimbleGen closes $8.2m venture round, bringing total to $50m
11. NimbleGen Systems CGS technique helps identify stomach bacteria
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/24/2017)... , Jan. 24, 2017 Vivonoetics Inc., ... announced today that in partnership with Great Lakes ... to the Roche FIREFISH study.    ... respiratory insufficiency due to progressive respiratory muscle weakness ... the spinal cord. This weakness results in ineffective ...
(Date:1/24/2017)... Jan. 24, 2017 Reha Technology USA ... Boston . The need for Robotic technology in ... is widely accepted in the surgical space. Project Walk – ... to traditional therapy and adding technology to their continuum of care. ... higher gait training repetitions which has been shown to improve gait ...
(Date:1/24/2017)... , Jan. 24, 2017 Relmada Therapeutics, Inc. ... the treatment of central nervous system (CNS) diseases, is ... and a recent meeting with the U.S. Food and ... the clinical development of LevoCap ER (REL-1015, levorphanol extended ... new drug application (NDA) filing is achievable.   ...
(Date:1/24/2017)... 2017  Applied BioMath ( www.appliedbiomath.com ), ... drug research and development, today announced their ... and Next-Generation Biologics: Innovative Strategies for Optimally ... PhD, Senior Scientist at Applied BioMath will ... mechanistic determinants of antibody drug-conjugate pharmacokinetics using ...
Breaking Biology Technology:
(Date:1/24/2017)... 24, 2017 Biopharm Reports has carried ... use of nuclear magnetic resonance spectroscopy (NMR). This ... profiled current practices, developments, trends and end-user plans ... growth and opportunities. These areas include growth in ... needs and innovation requirements, hyphenated NMR techniques, main ...
(Date:1/24/2017)... -- It sounds simple and harmless—an electronic sensor attached ... and alerts parents on their smart phones if, ... But pediatric experts argue that such devices may ... of medical benefits, especially to healthy babies. ... of healthy babies, promising peace of mind about ...
(Date:1/23/2017)... 23, 2017  The latest mobile market research from ... dropped dramatically. The quarterly average price of a biometric ... in Q4 2016.  There are now 120 sub-$150 models ... up from just 28 a year ago at an ... Maxine Most , Acuity Market Intelligence Principal, "Biometric ...
Breaking Biology News(10 mins):